Cart 0 $0.00
IRE favicon

Doctor's role in pharmaceutical study questioned

An investigation by John Fauber, of the Milwaukee Journal Sentinel, found that when doctors sign off on research about powerful new drugs, they may be doing so based on data provided them by drug companies – not the raw data that underlies the studies themselves.  Fauber looked at the case of Multaq, a drug for treating atrial fibrillation, and the chair of the University of Wisconsin School of Medicine and Public Health, who was part of a study on the drug. The doctor and his six co-authors all had ties to the drug company – with two working directly for the company and the five others moonlighting for the company as consultants or speakers.

109 Lee Hills Hall, Missouri School of Journalism   |   221 S. Eighth St., Columbia, MO 65201   |   573-882-2042   |   |   Privacy Policy
crossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
My cart
Your cart is empty.

Looks like you haven't made a choice yet.